- ►annals.org [PDF] GD Sanders, MA Hlatky, NR Every, KM … - Annals of internal medicine, 2001 - Am Coll Physicians Potential Cost-Effectiveness of Prophylactic Use of the Implantable ...
Cardioverter Defibrillator or Amiodarone after Myocardial Infarction ...
Gillian D. Sanders, PhD; Mark A. Hlatky, MD; Nathan R. Every, MD, MPH; ... Cited by 61 - Related articles - BL Direct - All 7 versions
DK Owens, GD Sanders, PA Heidenreich, KM … - American Heart Journal, 2002 - critcaremed.com From the a VA Health Care System, Palo Alto, b Center for Primary Care and
Outcomes Research, Department of Medicine, c Department of Health Research and
Policy, and the d Division of Cardiology, Department of Medicine, Stanford ... Cited by 49 - Related articles - Cached - BL Direct - All 7 versions
G Larsen, A Hallstrom, J McAnulty, S Pinski, … - Circulation, 2002 - Am Heart Assoc From the Cardiology Section (GL), Oregon VA Medical Center, Portland, Ore; AVID
Clinical Trial Center and University of Washington (AH, AO, JP), Seattle, Wash;
Division of Cardiology (JHM, CM, GL), Oregon Health Sciences University, ... Cited by 67 - Related articles - BL Direct - All 6 versions
- ►annals.org DK Owens, GD Sanders, RA Harris, KM … - Annals of Internal Medicine, 1997 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Background: Implantable cardioverter defibrillators (ICDs) are remarkably ... Cited by 164 - Related articles - BL Direct - All 5 versions
- ►ahajournals.org R Sheldon, BJ O'Brien, G Blackhouse, R … - Circulation, 2001 - Am Heart Assoc Methods and Results— Patients in CIDS were grouped according to whether they
had 2 of 3 risk factors. Incremental cost-effectiveness of ICD therapy was
computed as the ratio of the difference in mean cost to the difference in ... Cited by 45 - Related articles - BL Direct - All 4 versions
- ►usc.edu [PDF] L Chen, JW Hay - Cardiovascular Drugs and Therapy, 2004 - Springer Summary. Background: Implanted cardioverter defibrilla- tor (ICD) is expensive
but highly effective in preventing sudden death. The value of primary
prophylactic ICD in pre- venting sudden death for congestive heart failure ... Cited by 24 - Related articles - BL Direct - All 5 versions
JP Weiss, O Saynina, KM McDonald, MB … - The American journal of medicine, 2002 - Elsevier Patients who received a defibrillator were more likely to be younger, white,
male, and urban dwelling, and to have ischemic heart disease, heart failure, or
a history of ventricular fibrillation. In the matched-pairs analysis, those ... Cited by 36 - Related articles - All 6 versions
GC Larsen, AS Manolis, FA Sonnenberg, JR … - Journal of the American College of Cardiology, 1992 - Am Coll Cardio Found The implantable cardioverter-defibrillator (ICD) greatly reduces the incidence
of sudden cardiac death among patients with recurrent sustained ventricular
tachycardia and fibrillation who do not respond to conventional ... Cited by 92 - Related articles - All 3 versions
- ►ahajournals.org BJ O'Brien, SJ Connolly, R Goeree, G … - Circulation, 2001 - Am Heart Assoc Methods and Results—Healthcare resource use was collected prospectively on the
first 430 patients enrolled in CIDS (n=212 ICD, n=218 amiodarone). Mean cost per
patient, adjusted for censoring, was computed for each group based on ... Cited by 71 - Related articles - BL Direct - All 6 versions
MA Hlatky, GD Sanders, DK Owens - Cardiac Electrophysiology Review, 2003 - Springer Abstract. Many clinicians and policymakers are con- cerned whether use of the
implantable defibrillator (ICD) is justified in view of its high cost. Three
random- ized trials of the ICD have reported economic outcomes. Each trial ... Cited by 28 - Related articles - BL Direct - All 8 versions
